Viking Therapeutics: A Quiet Hope

These smaller companies, they live and die by their pipelines, don’t they? A single molecule holds so much hope, so much potential for… well, for not disappearing. For Viking, that molecule is VK2735, a dual GLP-1/GIP agonist. A rather grand name for a substance aiming to address the commonplace afflictions of obesity and diabetes. It’s a field teeming with ambition, and a quiet desperation.







